Arterial stiffness, vascular calcification and osteoporosis — common mechanisms of interaction (literature review)

O. Nishkumay, H.V. Mostbauer, O.O. Alekseenko, K.I. Moskalenko, P. Lazarev, M. Shevchuk
{"title":"Arterial stiffness, vascular calcification and osteoporosis — common mechanisms of interaction (literature review)","authors":"O. Nishkumay, H.V. Mostbauer, O.O. Alekseenko, K.I. Moskalenko, P. Lazarev, M. Shevchuk","doi":"10.22141/pjs.12.2.2022.333","DOIUrl":null,"url":null,"abstract":"Introduction. The problem of cardiovascular morbidity and mortality remains an urgent issue of modern medicine, and arterial stiffness is its independent predictor. Lively discussions about the correct approach to the prevention and treatment of comorbid conditions – increased vascular stiffness as an influential factor of the cardiovascular events and decreased bone mineral density (osteoporosis), primarily arise against the background of the need and safety of calcium and vitamin D supplements. The purpose was to search for literature data as for possible common pathogenetic links in the progression of arterial stiffness and the development of osteoporosis in order to assess the safety of the use of drugs to prevent osteoporotic fractures. Results. Analysis of literature sourses had showed that possible osteogenic factors affecting arterial stiffness may be: secondary hyperparathyroidism, disbalance of the RANK/RANKL/OPG system, inhibition of vitamin K-dependent matrix proteins (Gla-protein), osteopontin, etc. Conclusions. Today, there are many hypotheses confirming the possible influence of osteogenic factors on vascular stiffness and arterial calcification. Therefore, the search for sensitive markers and the development of screening protocols for the patients with risk factors for both osteoporosis and vascular changes are extremely relevant. A special issue is the possibility of using monotherapy for these comorbid pathologies, which can safely and efficiently influence the prevention of complications – both low-energy osteoporotic fractures and cardiovascular catastrophes. This will be the focus of our further research.","PeriodicalId":320219,"journal":{"name":"PAIN, JOINTS, SPINE","volume":"38 3","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PAIN, JOINTS, SPINE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22141/pjs.12.2.2022.333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction. The problem of cardiovascular morbidity and mortality remains an urgent issue of modern medicine, and arterial stiffness is its independent predictor. Lively discussions about the correct approach to the prevention and treatment of comorbid conditions – increased vascular stiffness as an influential factor of the cardiovascular events and decreased bone mineral density (osteoporosis), primarily arise against the background of the need and safety of calcium and vitamin D supplements. The purpose was to search for literature data as for possible common pathogenetic links in the progression of arterial stiffness and the development of osteoporosis in order to assess the safety of the use of drugs to prevent osteoporotic fractures. Results. Analysis of literature sourses had showed that possible osteogenic factors affecting arterial stiffness may be: secondary hyperparathyroidism, disbalance of the RANK/RANKL/OPG system, inhibition of vitamin K-dependent matrix proteins (Gla-protein), osteopontin, etc. Conclusions. Today, there are many hypotheses confirming the possible influence of osteogenic factors on vascular stiffness and arterial calcification. Therefore, the search for sensitive markers and the development of screening protocols for the patients with risk factors for both osteoporosis and vascular changes are extremely relevant. A special issue is the possibility of using monotherapy for these comorbid pathologies, which can safely and efficiently influence the prevention of complications – both low-energy osteoporotic fractures and cardiovascular catastrophes. This will be the focus of our further research.
动脉硬化、血管钙化和骨质疏松——相互作用的常见机制(文献综述)
介绍。心血管疾病的发病率和死亡率的问题仍然是一个紧迫的问题,现代医学和动脉僵硬是其独立的预测指标。关于预防和治疗合并症的正确方法的热烈讨论-血管僵硬增加是心血管事件的一个影响因素,骨密度降低(骨质疏松症),主要是在钙和维生素D补充剂的需求和安全性的背景下出现的。目的是寻找动脉僵硬发展和骨质疏松发生可能的共同致病联系的文献资料,以评估使用药物预防骨质疏松性骨折的安全性。结果。文献来源分析表明,影响动脉僵硬的可能成骨因素有:继发性甲状旁腺功能亢进、RANK/RANKL/OPG系统失衡、维生素k依赖性基质蛋白(gla -蛋白)、骨桥蛋白等抑制。结论。目前,有许多假说证实了成骨因子对血管僵硬和动脉钙化的可能影响。因此,寻找敏感的标志物和制定筛查方案对骨质疏松症和血管改变的危险因素的患者是非常重要的。一个特殊的问题是对这些合并症病理使用单一疗法的可能性,这可以安全有效地影响并发症的预防-包括低能量骨质疏松性骨折和心血管灾难。这将是我们进一步研究的重点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信